Back
Seelos Therapeutics Stock Price Chart
Sponsored
SEEL
Sponsored
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Sell
44
SEEL
Seelos Therapeutics
Last Price:
3.95
Seasonality Move:
3.92%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SEEL is experiencing selling pressure, which indicates risk of future bearish movement.
Seelos Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.29 | Buy |
20-day SMA: | 0.65 | Buy |
50-day SMA: | 0.47 | Buy |
200-day SMA: | 4.12 | Sell |
8-day EMA: | 1.88 | Buy |
20-day EMA: | 1.01 | Buy |
50-day EMA: | 0.75 | Buy |
200-day EMA: | 23.07 | Sell |
Seelos Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.57 | Buy |
Relative Strength Index (14 RSI): | 46.62 | Sell |
Chaikin Money Flow: | -731685 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-0.57 - 1.73) | Buy |
Bollinger Bands (100): | (0.01 - 1.59) | Buy |
Seelos Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Seelos Therapeutics Stock
Is Seelos Therapeutics Stock a Buy?
- Seelos Therapeutics share price is 3.90 while SEEL 8-day simple moving average is 1.29, which is a Buy signal.
- The stock price of SEEL is 3.90 while Seelos Therapeutics 20-day SMA is 0.65, which makes it a Buy.
- Seelos Therapeutics 50-day simple moving average is 0.47 while SEEL share price is 3.90, making it a Buy technically.
- SEEL stock price is 3.90 and Seelos Therapeutics 200-day simple moving average is 4.12, creating a Sell signal.
SEEL Technical Analysis vs Fundamental Analysis
Sell
44
Seelos Therapeutics (SEEL)
is a Sell
Is Seelos Therapeutics a Buy or a Sell?
-
Seelos Therapeutics stock is rated a Sell
The current Seelos Therapeutics [SEEL] share price is $3.90. The Score for SEEL is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Seelos Therapeutics Stock Info
Market Cap:
1.7M
Price in USD:
3.90
Share Volume:
1.31M
Seelos Therapeutics 52-Week Range
52-Week High:
848.64
52-Week Low:
2.90
Sell
44
Seelos Therapeutics (SEEL)
is a Sell
Seelos Therapeutics Share Price Forecast
-
What is the Seelos Therapeutics stock price today?
The Seelos Therapeutics stock price is 3.90 USD today. -
Will SEEL stock go up or go down?
Seelos Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Seelos Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Seelos Therapeutics is overvalued.
Is Seelos Therapeutics Stock a Buy?
- Seelos Therapeutics share price is 3.90 while SEEL 8-day exponential moving average is 1.88, which is a Buy signal.
- The stock price of SEEL is 3.90 while Seelos Therapeutics 20-day EMA is 1.01, which makes it a Buy.
- Seelos Therapeutics 50-day exponential moving average is 0.75 while SEEL share price is 3.90, making it a Buy technically.
- SEEL stock price is 3.90 and Seelos Therapeutics 200-day simple moving average is 23.07, creating a Sell signal.
Fundamental Analysis of Seelos Therapeutics
Is Seelos Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $304.80 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Seelos Therapeutics
Should I short Seelos Therapeutics stock?
- SEEL Moving Average Covergence Divergence (MACD) indicator is 0.57, suggesting Seelos Therapeutics is a Buy
- Seelos Therapeutics Relative Strength Index (RSI) is 46.62, which suggest Seelos Therapeutics is oversold
- The Bollinger Bands (25) for Seelos Therapeutics is (-0.57 - 1.73), which suggest Seelos Therapeutics is a Buy
- The Bollinger Bands (100) for Seelos Therapeutics is (0.01 - 1.59), which suggest Seelos Therapeutics is a Buy
* Seelos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.